pocketful logo light
pocketful logo light
Shukra Pharmaceuticals Ltd logo

Shukra Pharmaceuticals Ltd

NSE: BSE: 524632

₹58.59

(5.89%)

Fri, 25 Sept 2026, 08:47 am

Shukra Pharmaceuticals Share Price Live Chart

1 Day

(5.89%)

No Result Found

Summary

  • Market Cap (in Cr)

    1269.41

  • Net Profit (in Cr)

    9.58

  • P/B

    15.17

  • Sector P/E

    33.76

  • P/E

    99.32

  • EV/EBITDA

    56.04

  • Debt/Equity (Industry)

    0.26

  • Interest Cover (Industry)

    10.81

  • ROCE (Industry)

    16.40

  • RONW (Industry)

    14.39

  • ROE

    15.90

  • ROCE

    21.76

  • Debt/Equity

    0.06

  • EPS (TTM)

    0.50

  • Dividend Yield

    0

  • Book Value

    2.05

  • Interest Cover

    23.61

Analysis

No Result Found

Read More

Financials

Read More

Ratios

Read More

Shareholding

ShareholdersMAR 2026DEC 2025SEPT 2025JUN 2025MAR 2025
Promoters50.9650.9650.9650.9650.96
FII00000
DII0.110.110.110.110.11
Public48.9348.9348.9348.9348.93
Government00000

Read More

Technical Analysis

RSI

65.99

MACD

3.80

50 DMA

43.33

200 DMA

39.81

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic72.7256.4550.4340.1834.1623.917.64
Fibonacci56.4550.2346.4040.1833.9630.1323.91
Camarilla48.8847.3945.9040.1842.9241.4339.94

Pivots Level: Classic

R3

+32.54

72.72

R2

+16.27

56.45

R1

+10.25

50.43

40.18
40.18
Pivot Point
LTP: 55.86

S1

-6.02

34.16

S2

-16.27

23.91

S3

-32.54

7.64

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    55.36

  • 20-EMA

    52.73

  • 30-EMA

    50.08

  • 50-EMA

    46.05

  • 100-EMA

    41.38

  • 200-EMA

    37.93

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
07 May 2026board-meetingsAccounts, Final Dividend
04 Feb 2026board-meetingsQuarterly Results
13 Nov 2025board-meetingsQuarterly Results
04 Oct 2025egm
30 Aug 2025agm
18 Aug 2025dividendFinal Dividend - Rs. - 0.0118 Sept 2025
04 Jun 2025dividend₹0.01 Dividend /Share18 Sept 2025
21 Feb 2025splitStock Split From Rs.10 to Rs.121 Mar 2025
29 Jan 2025split1:10 Splits of Equity Shares21 Mar 2025
15 Sept 2024agm

Read More

Peer Comparison

Shukra Pharmaceuticals Ltd logo

Shukra Pharmaceuticals Ltd

Cipla Ltd logo

Cipla Ltd

Torrent Pharmaceuticals Ltd logo

Torrent Pharmaceuticals Ltd

Dr Reddys Laboratories Ltd logo

Dr Reddys Laboratories Ltd

Divis Laboratories Ltd logo

Divis Laboratories Ltd

Sun Pharmaceutical Industries Ltd logo

Sun Pharmaceutical Industries Ltd

Read More

Shukra Pharmaceuticals Ltd About

Shukra Pharmaceuticals is engaged primarily in the business of manufacture and marketing of pharmaceutical products.

Industry

Pharmaceuticals - Indian - Formulations

Founded

1993

Headquarters

CEO

Dakshesh Shah

Employees

Contact

Website icon

Website

http://www.shukrapharmaceuticals.com

Email icon

Email

info@shukrapharmaceuticals.com

Phone icon

Phone

91-079-66522247/27498515

Location icon

Location

3 rd Floor Dev House, Opp WIAA Office Judges Bungalo, Ahmedabad, Gujarat, 380054

Read More

Shukra Pharmaceuticals Ltd Company History

YearHistory
No Result Found

Read More

Deals

Client NameDeal TypeOrder SideQTYAvg PriceDate
No Result Found

Read More

Shukra Pharmaceuticals Ltd News

Shukra Pharma closes trading window for Q2FY27

Shukra Pharmaceuticals Ltd closes its trading window from October 1, 2026, for Q2FY27 results. Insiders barred from trading until 48 hours post-declaration.

24 Sept 2026

companies

Shukra Pharma issues corrigendum for name change to Medtech

Shukra Pharmaceuticals Ltd issued a corrigendum to its postal ballot notice regarding the name change to Shukra Medtech Limited. The update replaces the auditor's certificate with revised numerical parameters required by BSE.

22 Sept 2026

companies

Shukra Pharmaceuticals approves preferential issue

Shukra Pharmaceuticals approved the preferential issue of 46,43,000 convertible equity warrants to promoters. The resolution was passed during the EOGM held on July 06, 2026.

06 Jul 2026

companies

Shukra Pharmaceuticals appoints new Company Secretary

Shukra Pharmaceuticals appointed Shivkant Dhakad as Company Secretary effective June 15, 2026. Arpita Kabra resigned from the post on the same date.

15 Jun 2026

companies

Shukra Pharmaceuticals to ratify EGM resolution

Shukra Pharmaceuticals Ltd. will hold a board meeting on June 10, 2026, to ratify a member's resolution passed in the EGM dated November 1, 2025.

05 Jun 2026

companies

Read More

Frequently Asked Questions

  • 1.What is the stock price of Shukra Pharmaceuticals Ltd?

    As of 25/09/2026 at 2:17 PM, Shukra Pharmaceuticals Ltd shares are trading at ₹58.59.

  • 2.What is the market cap. of Shukra Pharmaceuticals Ltd?

    As of 25/09/2026, the market capitalization of Shukra Pharmaceuticals Ltd is ₹2,428.43 crore.

  • 3.When was Shukra Pharmaceuticals Ltd founded?

    Shukra Pharmaceuticals Ltd was founded in 1993.

  • 4.What are the P/E and P/B ratios of Shukra Pharmaceuticals Ltd?

    As of 25/09/2026, Shukra Pharmaceuticals Ltd has a P/E ratio of 75.60 and a P/B ratio of 15.17.

  • 5.How can I buy shares of Shukra Pharmaceuticals Ltd?

    You can buy shares of Shukra Pharmaceuticals Ltd through Pocketful. Simply open a Demat account, complete your KYC, add funds, and place a buy order.

  • 6.Does Shukra Pharmaceuticals Ltd pay dividends?

    Yes, Shukra Pharmaceuticals Ltd pays dividends to eligible shareholders. The latest dividend announced by the company was ₹Final Dividend - Rs. - 0.01 per share.

  • 7.What is the dividend yield of Shukra Pharmaceuticals Ltd?

    As of 25 September, 2026, the dividend yield of Shukra Pharmaceuticals Ltd stands at 0.02%.

  • 8.What are the latest financial results of Shukra Pharmaceuticals Ltd?

    For January,2024, Shukra Pharmaceuticals Ltd reported revenue of ₹32.59 crore and a net profit of ₹9.58 crore.

  • 9.Who is the CEO of Shukra Pharmaceuticals Ltd?

    The CEO of Shukra Pharmaceuticals Ltd is Dakshesh Shah.